Abstract
Infections of the feet of patients with diabetes mellitus comprise a heterogeneous group of clinical conditions. Peripheral neuropathy is the most important predisposing factor. Also important in many patients are impaired circulation and poor glucose control. Staphylococcus aureus and the beta-hemolytic streptococci are the main pathogens. Gram-negatives and anaerobes assume a greater role in the presence of chronic ulcerations and severe peripheral vascular disease. Osteomyelitis is more likely when the ulceration can be probed to the bone and when the ulcer is long-standing. MRI is the best imaging modality for confirming a diagnosis of osteomyelitis. Culture of bone obtained in the absence of antibiotic therapy is helpful in determining the microbiology and hence the therapeutic regimen. Whether the therapy is given orally or intravenously should be determined by the microbiology, the extent of the infection, and the general condition of the patient. Adjunctive surgical therapies are essential to a successful outcome in patients with necrotic tissue, dead bone, or impaired circulation. Duration of antibiotic therapy can be as short as 7 days for patients with superficial soft tissue infections and as long as 3 or 4 months in selected patients with advanced osteomyelitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13:513–21.
Frykberg RG. Diabetic foot ulcers: current concepts. J Foot Ankle Sur. 1998;37:440–6.
Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care. 1992;15:256–60.
Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259–65.
Wheat IJ, Allen SD, Henry M, et al. Diabetic foot infections. Bacteriologic analysis. Arch Intern Med. 1986;146(10):1935–40.
Lipsky BA, Pecoraro RE, Wheat LJ. The diabetic foot: soft tissue and bone infection. Infect Dis Clin North Am. 1990;7:467–81.
Jones EW, Edwards R, Finch R, Jeffcoate WJ. A microbiological study of diabetic foot lesions. Diabet Med. 1985;2:213–5.
Gerding DN. Foot infections in diabetics: the role of anaerobes. Clin Infect Dis. 1995;20 Suppl 2:S283–8.
Pathare NA, Bal A, Talvalkar GV, Antani DU. Diabetic foot infections: a study of microorganisms associated with different Wagner grades. Indian J Pathol Microbiol. 1998;41:437–41.
Bansal E, Garg A, Bhatia S, Attri AK, Chander J. Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol. 2008;51(2):204–8.
Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs. 2010;70(14):1784–97.
Pellizzer G, Strazzabosco M, Presi S, et al. Deep tissue biopsy vs superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med. 2001;18(10):822–7.
Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH. Outpatient management of uncomplicated lower extremity infections in diabetic patients. Arch Int Med. 1990;150(4):790–7.
Senneville E, Meliez H, Beltrand E, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis. 2006;42:57–62.
Crouzet J, Lavigne JP, Richard JC, Sotto A. Diabetic foot infection; a critical review of recent randomized clinical trials on antibiotic therapy. Int J Infect Dis. 2011;15(9):e601–10.
Lipsky BA, Peters EJ, Senneville E, Berendt AR, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev. 2012;28 Suppl 1:163–78.
Spellberg B, Lipsky BA. Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis. 2012;54(3):393–407.
Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited; efficacy of clindamycin, erythromycin and penicillin in streptococcal osteomyelitis. J Infect Dis. 1988;158(1):22–8.
Holtom PD, Zalavras CG, Lamp KC, Park N, Friedrich LV. Clinical experience with daptomycin treatment of foot and ankle osteomyelitis: a preliminary study. Clin Orthop Relat Res. 2007;461:35–9.
Traunmuller F, Schintler MV, Metzler J, et al. Soft Âtissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections. J Antimicrob Chemother. 2010;65:1252–7.
Nguyen S, Pasquet A, Legout L, et al. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections. Clin Microbiol Infect. 2009;15:1163–9.
Norden CW, Bryant R, Palmer D, Montgomerie JZ, Wheat J. Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy. South Med J. 1986;79:947–51.
Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39:885–910.
Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded multicenter trial of pexiganan cream. Clin Infect Dis. 2008;47(12):1537–45.
Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33(5):998–1003.
Gottrup F. Management of the diabetic foot: surgical and organisational aspects. Horm Metab Res. 2005;37 Suppl 1:69–75.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Scully, B. (2012). Diabetic Foot Infections: Microbiology and Antibiotic Therapy. In: Shrikhande, G., McKinsey, J. (eds) Diabetes and Peripheral Vascular Disease. Contemporary Diabetes. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-158-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-62703-158-5_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-157-8
Online ISBN: 978-1-62703-158-5
eBook Packages: MedicineMedicine (R0)